{"database": "lobbying", "table": "lobbying_activities", "rows": [[1594678, "c56633ad-de59-4e25-90ed-0102b861ea1e", "Q3", "BROWN RUDNICK LLP", 287895, "ZYDUS PHARMACEUTICALS USA INC.", 2014, "third_quarter", "PHA", "Issues relating to FDA generic drug approval; Generic Drug User Fee Amendments of 2012 (GDUFA)", "HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2014-10-17T15:44:16.187000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1594678"], "units": {}, "query_ms": 92.74013602407649, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}